Why an FDA Panel Saw Asthma Drugs Differently - Health Blog - WSJ
Links shared publicly online about this topic.
- 2,411total visits
Why an FDA Panel Saw Asthma Drugs Differently - Health Blog - WSJ
Serevent and Foradil, shouldn't be used for asthma anymore, and two other drugs, Advair and Symbicort, should remain an option, an FDA advisory panel recommended.
View full resource at feeds.wsjonline.com
Tags: Asthma, Asthma Medication, COPD Medication, Drug, FDA, Advair, Symbicort, Serevent
Most Recently Shared on December 12, 2008 at 2:16 pm By:
Why an FDA Panel Saw Asthma Drugs Differently http://bit.ly/h4V8
Advertisement
